Telemedicine Reports (May 2022)

Diabetes Education and Support Tele-Visit Needs Differ in Duration, Content, and Satisfaction in Older Versus Younger Adults

  • Margaret Greenfield,
  • Diana Stuber,
  • Danielle Stegman-Barber,
  • Karen Kemmis,
  • Belinda Matthews,
  • Carly B. Feuerstein-Simon,
  • Prasenjit Saha,
  • Beth Wells,
  • Teresa McArthur,
  • Christopher P. Morley,
  • Ruth S. Weinstock

DOI
https://doi.org/10.1089/TMR.2022.0007
Journal volume & issue
Vol. 3, no. 1
pp. 107 – 116

Abstract

Read online

Background: Diabetes education and support are critical components of diabetes care. During the COVID-19 pandemic, when telemedicine took the place of in-person visits, remote Certified Diabetes Care and Education Specialist (CDCES) services were offered to address diabetes education and support. Specific needs for older adults, including the time required to provide education and support remotely, have not been previously reported. Methods: Adults with diabetes (primarily insulin-requiring) were referred to remote CDCESs. Utilization was individualized based on patient needs and preferences. Topics discussed, patient satisfaction, and time spent in each tele-visit were evaluated by diabetes type, age, sex, insurance type, glycosylated hemoglobin (HbA1c), pump, and continuous glucose monitor (CGM) usage. t-Tests, one-way analysis of variance, and Pearson correlations were employed as appropriate. Results: Adults (n?=?982; mean age 48.4 years, 41.0% age ?55 years) with type 1 diabetes (n?=?846) and type 2 diabetes mellitus (n?=?136, 86.0% insulin-treated), 50.8% female; 19.0% Medicaid, 29.1% Medicare, 48.9% private insurance; mean HbA1c 8.4% (standard deviation 1.9); and 46.6% pump and 64.5% CGM users had 2203 tele-visits with remote CDCESs over 5 months. Of those referred, 272 (21.7%) could not be reached or did not receive education/support. Older age (?55 years), compared with 36?54 year olds and 18?35 year olds, respectively, was associated with more tele-visits (mean 2.6 vs. 2.2 and 1.8) and more time/tele-visits (mean 20.4?min vs. 16.5?min and 14.8?min; p?<?0.001) as was coverage with Medicare (mean 2.8 visits) versus private insurance (mean 2.0 visits; p?<?0.001) and lower participant satisfaction. The total mean time spent with remote CDCESs was 53.1, 37.4, and 26.2?min for participants aged ?55, 36?54, and 18?35 years, respectively. During remote tele-visits, the most frequently discussed topics per participant were CGM and insulin pump use (73.4% and 49.7%). After adjustment for sex and diabetes type, older age was associated with lack of access to a computer, tablet, smartphone, or internet (p?<?0.001), and need for more education related to CGM (p?<?0.001), medications (p?=?0.015), hypoglycemia (p?=?0.044), and hyperglycemia (p?=?0.048). Discussion: Most remote CDCES tele-visits were successfully completed. Older adults/those with Medicare required more time to fulfill educational needs. Although 85.7% of individual sessions lasted <30?min, which does not meet current Medicare requirements for reimbursement, multiple visits were common with a total time of >50?min for most older participants. This suggests that new reimbursement models are needed. Education/support needs of insulin-treated older adults should be a focus of future studies.

Keywords